List of Excipients in API ivosidenib
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ivosidenib
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Servier Pharmaceutical LLC | TIBSOVO | ivosidenib | 72694-617 | CELLULOSE, MICROCRYSTALLINE | 2035-03-13 |
| Servier Pharmaceutical LLC | TIBSOVO | ivosidenib | 72694-617 | CROSCARMELLOSE SODIUM | 2035-03-13 |
| Servier Pharmaceutical LLC | TIBSOVO | ivosidenib | 72694-617 | FD&C BLUE NO. 2 | 2035-03-13 |
| Servier Pharmaceutical LLC | TIBSOVO | ivosidenib | 72694-617 | HYPROMELLOSE | 2035-03-13 |
| Servier Pharmaceutical LLC | TIBSOVO | ivosidenib | 72694-617 | HYPROMELLOSE ACETATE SUCCINATE 06081224 | 2035-03-13 |
| Servier Pharmaceutical LLC | TIBSOVO | ivosidenib | 72694-617 | LACTOSE MONOHYDRATE | 2035-03-13 |
| Servier Pharmaceutical LLC | TIBSOVO | ivosidenib | 72694-617 | MAGNESIUM STEARATE | 2035-03-13 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ivosidenib
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ivosidenib drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
ivosidenib drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
ivosidenib drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ivosidenib drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE ACETATE SUCCINATE 06081224
ivosidenib drug variants containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing HYPROMELLOSE ACETATE SUCCINATE 06081224
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
ivosidenib drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ivosidenib drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ivosidenib drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
ivosidenib drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ivosidenib drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
ivosidenib drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Servier Pharmaceutical LLC | ivosidenib | 72694-617 |
| >Company | >Ingredient | >NDC |
ivosidenib drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
